Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: ECM-receptor interaction (mmu04512)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
1110001D
15Rik
KLA  ATP  ATP+KLA
 NM_026763 RIKEN cDNA 1110001D15 gene (1110001D15Rik), mRNA [NM_026763] KLA 1.01 1.00 1.05 1.06 1.06 1.07 1.04
ATP 1.03 1.02 1.06 1.03 1.09 1.11 .95
KLA/ATP 1.04 1.02 1.07 1.05 1.01 1.06 1.04
Agrn
KLA  ATP  ATP+KLA
 AK147577 cDNA, RIKEN full-length enriched library, clone:M5C1082B14 product:agrin, full insert sequence [AK147577] KLA .95 1.05 1.00 1.05 1.02 1.07 1.04
ATP 1.02 1.00 1.02 1.03 .99 .97 .98
KLA/ATP 1.02 1.03 .93 1.01 1.02 1.02 .95
Agrn
KLA  ATP  ATP+KLA
 NM_021604 agrin (Agrn), mRNA [NM_021604] KLA 5.07 4.00 3.60 3.14 2.43 1.92 1.71
ATP .94 .80 1.22 .81 1.28 3.02 1.46
KLA/ATP 4.33 4.21 5.43 2.89 3.56 2.86 1.52
AK044510
KLA  ATP  ATP+KLA
 AK044510 adult retina cDNA, RIKEN full-length enriched library, clone:A930017M14 product:laminin, alpha 1, full insert sequence. [AK044510] KLA .96 1.07 1.03 1.05 1.00 1.06 1.16
ATP 1.04 1.04 1.04 1.04 1.05 1.08 1.01
KLA/ATP .96 1.08 1.07 1.10 1.12 1.08 1.01
BC010335
KLA  ATP  ATP+KLA
 BC010335 fibronectin 1, mRNA (cDNA clone IMAGE:3156499), **** WARNING: chimeric clone ****. [BC010335] KLA .94 .88 1.01 .99 .95 .95 1.07
ATP 1.06 .98 1.20 1.30 1.07 .97 .97
KLA/ATP .93 1.00 1.07 1.20 1.02 .96 .94
Cd36
KLA  ATP  ATP+KLA
 L23108 CD36 antigen mRNA, complete cds. [L23108] KLA .75 .74 .73 .57 .51 .40 .54
ATP .94 .93 .74 .61 .63 1.01 2.07
KLA/ATP .70 .67 .53 .47 .40 .58 1.13
Cd36
KLA  ATP  ATP+KLA
 NM_007643 CD36 antigen (Cd36), mRNA [NM_007643] KLA .70 .75 .67 .54 .45 .35 .42
ATP 1.06 1.04 .73 .58 .62 .81 1.44
KLA/ATP .83 .73 .45 .46 .35 .45 .82
Cd44
KLA  ATP  ATP+KLA
 NM_009851 CD44 antigen (Cd44), transcript variant 1, mRNA [NM_009851] KLA 1.87 1.86 1.79 1.42 .99 .54 .67
ATP 1.05 1.16 1.24 1.67 1.79 1.37 .85
KLA/ATP 2.00 2.08 1.53 1.86 1.24 .89 .71
Cd47
KLA  ATP  ATP+KLA
 AK164165 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630029O17 product:CD47 antigen (Rh-related antigen, integrin-associated signal transducer), full insert sequence [AK164165] KLA 2.94 2.62 2.85 3.10 3.14 2.72 1.46
ATP 1.04 1.09 .99 .86 .96 .59 .43
KLA/ATP 2.81 2.82 2.51 2.16 1.92 1.35 .51
Cd47
KLA  ATP  ATP+KLA
 NM_010581 CD47 antigen (Rh-related antigen, integrin-associated signal transducer) (Cd47), mRNA [NM_010581] KLA 3.06 3.27 3.52 3.68 4.33 4.69 3.32
ATP 1.08 1.02 .91 .94 1.18 1.76 2.69
KLA/ATP 3.38 3.42 2.52 2.95 2.47 3.27 5.66
Chad
KLA  ATP  ATP+KLA
 NM_007689 chondroadherin (Chad), mRNA [NM_007689] KLA 1.34 1.32 1.36 1.26 1.27 1.30 1.31
ATP 1.03 .94 1.16 1.08 1.12 1.37 1.26
KLA/ATP 1.36 1.44 1.52 1.57 1.32 1.42 1.56
Col11a1
KLA  ATP  ATP+KLA
 AK021265 12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530001D20 product:unclassifiable, full insert sequence. [AK021265] KLA 1.02 1.01 1.03 1.06 1.02 1.03 1.05
ATP .97 .92 1.02 .96 .93 1.11 1.00
KLA/ATP 1.01 .96 .97 1.00 1.04 .89 1.08
Col11a1
KLA  ATP  ATP+KLA
 NM_007729 collagen, type XI, alpha 1 (Col11a1), mRNA [NM_007729] KLA 1.06 1.06 1.10 1.05 1.07 1.01 1.09
ATP .97 .93 .95 1.03 .96 1.01 1.05
KLA/ATP 1.03 .98 1.02 1.02 .97 .99 1.05
Col11a2
KLA  ATP  ATP+KLA
 NM_009926 collagen, type XI, alpha 2 (Col11a2), mRNA [NM_009926] KLA 5.62 5.61 5.24 4.99 3.69 1.95 1.14
ATP .95 .95 1.17 1.59 1.73 1.28 1.12
KLA/ATP 5.25 5.62 6.37 5.73 4.79 2.22 1.39
Col1a1
KLA  ATP  ATP+KLA
 NM_007742 collagen, type I, alpha 1 (Col1a1), mRNA [NM_007742] KLA 1.13 1.10 1.22 1.18 1.04 1.15 1.09
ATP 1.03 1.00 1.34 1.48 1.11 1.13 1.11
KLA/ATP 1.13 1.29 1.47 1.77 1.38 1.33 1.13
Col1a2
KLA  ATP  ATP+KLA
 AK031577 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030456A07 product:procollagen, type I, alpha 2, full insert sequence. [AK031577] KLA .98 1.03 1.02 1.01 1.03 1.01 .90
ATP .97 .96 .96 1.00 .92 1.00 1.00
KLA/ATP .97 1.00 1.02 1.06 .96 .98 1.00
Col1a2
KLA  ATP  ATP+KLA
 NM_007743 collagen, type I, alpha 2 (Col1a2), mRNA [NM_007743] KLA 1.25 1.20 1.58 1.41 1.32 1.51 1.08
ATP .92 .97 1.50 1.66 1.38 1.23 1.14
KLA/ATP 1.35 1.46 2.19 2.47 1.99 1.64 1.36
Col24a1
KLA  ATP  ATP+KLA
 NM_027770 collagen, type XXIV, alpha 1 (Col24a1), mRNA [NM_027770] KLA .96 1.03 .95 .99 1.01 1.02 .98
ATP .98 1.03 1.04 1.04 .95 .99 1.00
KLA/ATP 1.04 .98 1.01 .99 1.01 .93 .96
Col27a1
KLA  ATP  ATP+KLA
 AK076297 0 day neonate skin cDNA, RIKEN full-length enriched library, clone:4632427K15 product:procollagen, type XXVII, alpha 1, full insert sequence. [AK076297] KLA 1.19 1.39 1.10 1.06 1.01 1.04 .96
ATP 1.00 .99 1.02 .99 1.01 1.06 1.08
KLA/ATP 1.23 1.26 1.12 1.10 1.12 .95 1.03
Col27a1
KLA  ATP  ATP+KLA
 NM_025685 collagen, type XXVII, alpha 1 (Col27a1), mRNA [NM_025685] KLA 3.10 3.05 2.89 1.86 1.37 1.14 1.16
ATP 1.02 1.00 1.10 1.22 1.24 1.15 1.12
KLA/ATP 3.43 3.57 2.62 1.99 1.42 1.23 1.24
Col2a1
KLA  ATP  ATP+KLA
 AK053784 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130308G17 product:unclassifiable, full insert sequence. [AK053784] KLA .95 .97 1.05 .93 .94 .94 .98
ATP .99 .91 .97 .87 .99 1.03 .93
KLA/ATP .95 1.05 .95 1.01 .97 .97 1.00
Col2a1
KLA  ATP  ATP+KLA
 NM_031163 collagen, type II, alpha 1 (Col2a1), transcript variant 1, mRNA [NM_031163] KLA 1.20 1.28 1.29 1.21 1.33 1.24 1.21
ATP .98 1.02 1.02 1.09 1.02 1.01 1.09
KLA/ATP 1.33 1.28 1.09 1.32 1.15 1.12 1.17
Col3a1
KLA  ATP  ATP+KLA
 AK031544 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030449K06 product:PROCOLLAGEN, TYPE III, ALPHA 1 (FRAGMENT) homolog [Mus musculus], full insert sequence. [AK031544] KLA 1.04 .95 1.01 1.04 1.04 1.03 .97
ATP 1.00 .98 1.02 1.00 1.03 1.00 .98
KLA/ATP 1.11 1.03 1.05 .90 .95 1.01 .97
Col3a1
KLA  ATP  ATP+KLA
 NM_009930 collagen, type III, alpha 1 (Col3a1), mRNA [NM_009930] KLA 1.06 1.08 1.02 .99 1.02 1.03 .99
ATP .97 1.01 1.07 1.01 .92 .94 .99
KLA/ATP .97 .99 1.09 1.11 .98 1.00 1.02
Col4a1
KLA  ATP  ATP+KLA
 NM_009931 collagen, type IV, alpha 1 (Col4a1), mRNA [NM_009931] KLA 1.13 1.19 1.12 1.09 1.04 .89 .90
ATP 1.01 1.17 1.02 1.04 .91 .89 .97
KLA/ATP 1.14 1.24 1.03 1.15 .95 .86 1.01
Col4a2
KLA  ATP  ATP+KLA
 NM_009932 collagen, type IV, alpha 2 (Col4a2), mRNA [NM_009932] KLA 1.30 1.45 1.54 1.40 1.71 1.71 2.12
ATP 1.09 1.07 .98 1.03 .92 1.21 1.42
KLA/ATP 1.45 1.53 1.24 1.29 1.16 1.57 3.31
Col4a3
KLA  ATP  ATP+KLA
 NM_007734 collagen, type IV, alpha 3 (Col4a3), mRNA [NM_007734] KLA 1.09 1.11 1.12 1.10 1.05 1.06 1.04
ATP 1.02 1.03 1.01 .99 1.01 1.07 1.07
KLA/ATP 1.04 1.13 1.01 1.09 1.02 .98 1.01
Col4a4
KLA  ATP  ATP+KLA
 NM_007735 collagen, type IV, alpha 4 (Col4a4), mRNA [NM_007735] KLA 1.35 1.29 1.33 1.39 1.30 1.18 .98
ATP 1.14 1.08 1.30 1.54 1.54 1.34 .93
KLA/ATP 1.37 1.41 1.70 1.88 1.67 1.29 1.19
Col4a5
KLA  ATP  ATP+KLA
 NM_007736 collagen, type IV, alpha 5 (Col4a5), mRNA [NM_007736] KLA 1.00 .95 .95 .82 .72 .58 .70
ATP 1.05 1.18 .98 .88 .56 .53 .57
KLA/ATP 1.04 1.05 .83 .82 .58 .49 .61
Col4a6
KLA  ATP  ATP+KLA
 NM_053185 collagen, type IV, alpha 6 (Col4a6), mRNA [NM_053185] KLA 1.06 1.04 1.00 1.07 .94 .93 .94
ATP .97 .96 1.18 1.10 1.07 1.04 .86
KLA/ATP 1.00 1.05 1.22 1.06 1.12 1.02 .93
Col5a1
KLA  ATP  ATP+KLA
 NM_015734 collagen, type V, alpha 1 (Col5a1), mRNA [NM_015734] KLA 1.00 .99 1.07 1.01 1.03 1.01 1.10
ATP 1.02 .98 1.02 1.07 .96 1.01 1.09
KLA/ATP 1.03 1.01 1.08 1.08 1.01 1.09 1.08
Col5a2
KLA  ATP  ATP+KLA
 NM_007737 collagen, type V, alpha 2 (Col5a2), mRNA [NM_007737] KLA .96 1.01 1.12 1.03 .99 .98 .90
ATP .99 1.06 1.05 1.10 .90 .98 1.06
KLA/ATP .95 1.01 1.05 1.11 1.07 1.04 1.14
Col5a3
KLA  ATP  ATP+KLA
 NM_016919 collagen, type V, alpha 3 (Col5a3), mRNA [NM_016919] KLA 1.33 1.48 1.48 1.47 1.45 1.31 1.08
ATP 1.06 1.02 1.08 1.06 1.07 1.35 1.48
KLA/ATP 1.42 1.50 1.42 1.45 1.27 1.32 1.37
Col6a1
KLA  ATP  ATP+KLA
 NM_009933 collagen, type VI, alpha 1 (Col6a1), mRNA [NM_009933] KLA 1.08 1.12 1.29 1.16 1.17 .96 1.03
ATP 1.05 1.03 1.01 1.07 .98 .96 .88
KLA/ATP 1.16 1.18 .92 1.17 1.01 .98 .92
Col6a2
KLA  ATP  ATP+KLA
 AK044870 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130009B12 product:procollagen, type VI, alpha 2, full insert sequence. [AK044870] KLA 1.06 1.00 .99 .96 .96 1.00 1.01
ATP .95 .95 .92 1.10 1.09 1.03 1.01
KLA/ATP 1.01 .97 .98 1.04 .98 1.04 .96
Col6a2
KLA  ATP  ATP+KLA
 NM_146007 collagen, type VI, alpha 2 (Col6a2), mRNA [NM_146007] KLA .94 1.06 1.00 1.07 1.05 1.04 1.00
ATP 1.01 .99 1.02 1.01 1.00 1.01 .98
KLA/ATP 1.01 .99 1.04 1.01 1.08 1.01 .95
Col6a3
KLA  ATP  ATP+KLA
 AF034136 collagen alpha3(VI) (Col6a3) mRNA, partial cds [AF034136] KLA .97 1.00 1.03 1.00 1.03 1.04 1.06
ATP 1.00 .93 1.00 1.01 1.07 .97 1.01
KLA/ATP 1.08 1.04 1.05 1.04 .99 1.10 1.02
Comp
KLA  ATP  ATP+KLA
 NM_016685 cartilage oligomeric matrix protein (Comp), mRNA [NM_016685] KLA 1.02 1.09 1.18 1.08 .96 1.12 .97
ATP .89 1.02 .97 .95 1.13 2.59 1.24
KLA/ATP 1.09 1.09 1.03 .98 1.60 2.02 1.15
Dag1
KLA  ATP  ATP+KLA
 NM_010017 dystroglycan 1 (Dag1), mRNA [NM_010017] KLA .74 .75 .67 .59 .62 .61 .66
ATP 1.16 1.24 .87 1.18 1.00 .91 1.17
KLA/ATP .88 .84 .53 .70 .75 .96 .90
E330026B
02Rik
KLA  ATP  ATP+KLA
 NM_172927 RIKEN cDNA E330026B02 gene (E330026B02Rik), transcript variant 2, mRNA [NM_172927] KLA .94 .98 1.02 1.02 .97 1.05 .99
ATP .97 .94 .98 1.02 1.02 .99 1.02
KLA/ATP 1.01 .99 1.03 1.04 .96 .97 .94
Fn1
KLA  ATP  ATP+KLA
 NM_010233 fibronectin 1 (Fn1), mRNA [NM_010233] KLA 1.23 1.30 1.38 1.12 1.16 1.00 .78
ATP 1.02 1.19 1.25 1.56 1.33 1.05 .95
KLA/ATP 1.36 1.51 1.34 1.70 1.20 1.06 .93
Gp1ba
KLA  ATP  ATP+KLA
 NM_010326 glycoprotein 1b, alpha polypeptide (Gp1ba), mRNA [NM_010326] KLA .92 1.01 .99 1.00 1.02 1.03 1.08
ATP 1.00 1.09 .97 .98 1.03 .99 1.09
KLA/ATP 1.03 1.04 1.08 1.08 .97 1.06 .97
Gp1bb
KLA  ATP  ATP+KLA
 NM_001001999 glycoprotein Ib, beta polypeptide (Gp1bb), transcript variant 1, mRNA [NM_001001999] KLA 1.03 1.04 1.10 1.03 1.16 1.17 1.15
ATP .99 .99 1.05 1.17 1.12 1.23 1.09
KLA/ATP 1.05 1.11 1.10 1.16 1.10 1.15 1.21
Gp5
KLA  ATP  ATP+KLA
 NM_008148 glycoprotein 5 (platelet) (Gp5), mRNA [NM_008148] KLA .93 1.00 1.04 1.01 .99 1.00 .96
ATP 1.04 .99 1.07 1.41 1.30 1.22 1.05
KLA/ATP 1.01 1.07 1.04 1.12 1.15 1.33 1.11
Gp6
KLA  ATP  ATP+KLA
 XM_145298 gb|PREDICTED: Mus musculus glycoprotein 6 (platelet) (Gp6), mRNA [XM_145298] KLA 1.12 1.13 1.18 1.17 1.10 1.27 1.48
ATP 1.07 1.08 1.11 1.16 1.03 1.11 1.24
KLA/ATP 1.14 1.07 1.13 1.19 1.25 1.32 3.36
Gp9
KLA  ATP  ATP+KLA
 NM_018762 glycoprotein 9 (platelet) (Gp9), mRNA [NM_018762] KLA 1.07 1.00 1.05 1.02 1.09 .98 1.02
ATP .97 .97 1.03 1.02 1.03 1.00 1.01
KLA/ATP 1.04 1.02 1.05 1.06 1.07 .93 1.06
Hmmr
KLA  ATP  ATP+KLA
 NM_013552 hyaluronan mediated motility receptor (RHAMM) (Hmmr), mRNA [NM_013552] KLA .61 .58 .59 .61 .45 .42 .26
ATP 1.01 1.16 1.06 1.12 .67 .57 .19
KLA/ATP .63 .59 .61 .70 .50 .41 .24
Ibsp
KLA  ATP  ATP+KLA
 NM_008318 integrin binding sialoprotein (Ibsp), mRNA [NM_008318] KLA .99 1.02 1.05 .96 .98 .96 .97
ATP .98 .99 .99 .96 1.00 1.02 1.00
KLA/ATP 1.01 1.07 1.03 .93 .93 .95 .95
Itga1
KLA  ATP  ATP+KLA
 NM_001033228 integrin alpha 1 (Itga1), mRNA [NM_001033228] KLA 1.08 1.09 1.13 1.05 1.04 .99 1.01
ATP 1.02 .97 1.03 1.03 1.09 1.43 3.50
KLA/ATP 1.06 1.04 1.07 1.00 1.06 1.12 1.33
Itga10
KLA  ATP  ATP+KLA
 NM_001081053 integrin, alpha 10 (Itga10), mRNA [NM_001081053] KLA .98 1.00 1.00 1.04 1.04 .96 1.00
ATP 1.05 1.00 .97 .98 .95 .96 .97
KLA/ATP 1.04 .98 .92 .96 .95 .97 1.00
Itga11
KLA  ATP  ATP+KLA
 NM_176922 integrin, alpha 11 (Itga11), mRNA [NM_176922] KLA .95 .92 .90 .97 .93 .93 .96
ATP .97 .92 .98 .95 .90 .94 .95
KLA/ATP .86 .94 1.01 .93 .97 .94 .88
Itga2
KLA  ATP  ATP+KLA
 NM_008396 integrin alpha 2 (Itga2), mRNA [NM_008396] KLA 1.03 1.00 .98 1.01 .97 .96 1.00
ATP 1.05 .99 .93 1.02 1.04 1.03 .97
KLA/ATP .98 1.06 1.03 1.00 1.00 1.01 1.01
Itga2b
KLA  ATP  ATP+KLA
 NM_010575 integrin alpha 2b (Itga2b), mRNA [NM_010575] KLA 1.01 1.00 .98 1.04 1.01 1.04 1.18
ATP 1.01 .98 .95 1.02 .96 1.13 1.08
KLA/ATP 1.04 1.02 1.02 .95 1.05 1.53 1.23
Itga3
KLA  ATP  ATP+KLA
 NM_013565 integrin alpha 3 (Itga3), mRNA [NM_013565] KLA 1.06 1.09 1.10 1.17 1.19 1.29 1.41
ATP .99 .99 1.05 1.12 1.20 1.25 1.33
KLA/ATP 1.08 1.14 1.15 1.27 1.28 1.20 1.39
Itga4
KLA  ATP  ATP+KLA
 NM_010576 integrin alpha 4 (Itga4), mRNA [NM_010576] KLA 4.65 4.83 4.47 3.76 2.93 1.65 1.01
ATP 1.10 1.12 1.17 1.08 .86 .75 .36
KLA/ATP 4.82 5.02 4.43 3.69 2.11 1.13 .79
Itga5
KLA  ATP  ATP+KLA
 NM_010577 integrin alpha 5 (fibronectin receptor alpha) (Itga5), mRNA [NM_010577] KLA 2.63 3.04 2.81 2.47 4.61 5.45 4.90
ATP 1.13 1.62 .74 2.21 1.31 1.93 2.84
KLA/ATP 3.55 3.84 1.15 3.03 1.11 2.81 10.42
Itga6
KLA  ATP  ATP+KLA
 BC024571 integrin alpha 6, mRNA (cDNA clone IMAGE:5036677). [BC024571] KLA .44 .44 .37 .28 .25 .29 .34
ATP .96 1.01 .90 .58 .35 .11 .22
KLA/ATP .44 .41 .34 .23 .15 .09 .08
Itga6
KLA  ATP  ATP+KLA
 NM_008397 integrin alpha 6 (Itga6), mRNA [NM_008397] KLA .57 .58 .51 .45 .43 .44 .47
ATP 1.05 1.12 .86 .90 .57 .27 .36
KLA/ATP .64 .67 .50 .57 .39 .29 .26
Itga7
KLA  ATP  ATP+KLA
 L23423 gb|Mouse (BALB/c) alpha-7 integrin mRNA, complete cds. [L23423] KLA .96 1.03 1.00 1.07 1.02 1.07 1.14
ATP 1.00 1.00 1.04 1.88 2.09 1.34 1.16
KLA/ATP 1.04 .97 1.07 1.79 1.68 1.39 1.11
Itga7
KLA  ATP  ATP+KLA
 NM_008398 integrin alpha 7 (Itga7), mRNA [NM_008398] KLA .98 .95 .98 1.01 1.04 1.03 .98
ATP 1.00 1.02 1.06 1.75 1.92 1.20 1.02
KLA/ATP 1.03 1.07 1.06 1.48 1.58 1.23 1.05
Itga8
KLA  ATP  ATP+KLA
 NM_001001309 integrin alpha 8 (Itga8), mRNA [NM_001001309] KLA .80 .81 .79 .75 .63 .61 .44
ATP .98 1.04 1.06 .94 .79 .61 .50
KLA/ATP .79 .81 .81 .71 .70 .65 .48
Itgav
KLA  ATP  ATP+KLA
 AK052514 13 days embryo lung cDNA, RIKEN full-length enriched library, clone:D430040G12 product:hypothetical protein, full insert sequence. [AK052514] KLA 1.04 .93 1.05 1.02 1.01 .93 1.03
ATP 1.05 1.04 1.13 1.12 1.12 .91 1.02
KLA/ATP 1.08 .97 1.02 .95 1.01 .96 1.05
Itgav
KLA  ATP  ATP+KLA
 AK171739 activated spleen cDNA, RIKEN full-length enriched library, clone:F830008B15 product:unclassifiable, full insert sequence. [AK171739] KLA 1.04 .97 1.06 .95 1.15 .89 1.11
ATP 1.41 1.54 1.64 2.24 2.74 1.24 1.18
KLA/ATP 1.09 1.07 1.03 1.01 1.72 1.24 1.10
Itgav
KLA  ATP  ATP+KLA
 NM_008402 integrin alpha V (Itgav), mRNA [NM_008402] KLA 4.00 3.99 3.28 2.24 1.57 .95 1.13
ATP 1.14 1.22 1.13 1.39 2.22 2.47 1.70
KLA/ATP 4.59 4.61 2.48 2.44 1.60 1.88 2.56
Itgb1
KLA  ATP  ATP+KLA
 NM_010578 integrin beta 1 (fibronectin receptor beta) (Itgb1), mRNA [NM_010578] KLA 1.05 1.09 1.13 .92 1.01 .93 .88
ATP 1.14 1.30 .92 1.07 1.04 .83 .70
KLA/ATP 1.26 1.30 .87 1.02 .66 .65 .62
Itgb1
KLA  ATP  ATP+KLA
 U37029 integrin beta1D mRNA, partial cds. [U37029] KLA .93 .95 .96 1.01 .97 1.01 .98
ATP 1.05 .99 .99 1.03 1.03 .97 .94
KLA/ATP .99 .98 1.04 .97 1.02 1.01 .99
Itgb3
KLA  ATP  ATP+KLA
 AF026509 integrin beta3 subunit mRNA, complete cds. [AF026509] KLA 2.38 2.64 2.65 3.15 4.02 4.46 2.83
ATP 1.21 1.17 1.25 1.62 2.33 3.09 4.78
KLA/ATP 2.48 2.63 3.39 3.72 4.30 4.71 6.79
Itgb3
KLA  ATP  ATP+KLA
 NM_016780 integrin beta 3 (Itgb3), mRNA [NM_016780] KLA .50 .51 .52 .41 .31 .25 .15
ATP .94 .88 1.17 .89 .99 1.36 .91
KLA/ATP .51 .54 .67 .52 .61 .74 .48
Itgb4
KLA  ATP  ATP+KLA
 AK048888 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230078O20 product:integrin beta 4, full insert sequence. [AK048888] KLA .98 .92 .98 1.08 .97 1.02 1.02
ATP .99 .99 .91 1.03 1.02 1.00 1.05
KLA/ATP .99 1.03 .99 .98 .94 .98 1.01
Itgb4
KLA  ATP  ATP+KLA
 NM_001005608 integrin beta 4 (Itgb4), transcript variant 1, mRNA [NM_001005608] KLA 1.09 1.11 1.12 1.08 .98 .86 .85
ATP .90 .89 .90 .95 .87 .87 .84
KLA/ATP 1.06 1.08 1.10 1.18 1.07 .90 .76
Itgb5
KLA  ATP  ATP+KLA
 NM_010580 integrin beta 5 (Itgb5), mRNA [NM_010580] KLA .72 .68 .67 .66 .54 .43 .36
ATP 1.09 .94 .78 .57 .63 .56 .62
KLA/ATP .78 .64 .67 .51 .64 .67 .38
Itgb6
KLA  ATP  ATP+KLA
 NM_021359 integrin beta 6 (Itgb6), mRNA [NM_021359] KLA .97 1.02 1.04 1.06 1.06 1.04 1.01
ATP .99 1.00 1.01 .96 1.04 1.00 1.00
KLA/ATP .99 1.03 1.08 1.02 1.02 1.03 1.01
Itgb7
KLA  ATP  ATP+KLA
 NM_013566 integrin beta 7 (Itgb7), mRNA [NM_013566] KLA .91 .88 .93 1.19 .93 .76 .79
ATP 1.00 .96 1.30 1.44 2.84 3.07 7.90
KLA/ATP .96 1.05 1.35 1.20 2.70 3.53 8.17
Itgb8
KLA  ATP  ATP+KLA
 AK029281 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832412O06 product:SIMILAR TO INTEGRIN, BETA 8 homolog [Homo sapiens], full insert sequence. [AK029281] KLA 4.66 5.00 3.59 2.70 1.76 1.34 1.32
ATP 1.01 .98 1.09 1.16 2.15 5.24 1.17
KLA/ATP 5.59 6.39 4.38 1.99 1.84 2.55 2.11
Itgb8
KLA  ATP  ATP+KLA
 AK034644 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430018C17 product:integrin beta 8, full insert sequence. [AK034644] KLA 1.18 1.02 1.04 1.03 1.05 .94 .93
ATP .96 .97 .97 .96 .90 1.04 .99
KLA/ATP 1.06 1.06 1.15 .92 .99 1.00 1.09
Itgb8
KLA  ATP  ATP+KLA
 AK140969 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130086L01 product:hypothetical protein, full insert sequence [AK140969] KLA 3.63 3.76 4.16 3.31 2.72 1.58 1.40
ATP .98 1.01 1.31 1.14 1.28 6.11 1.65
KLA/ATP 3.84 4.18 3.75 2.83 1.92 3.44 4.81
Lama1
KLA  ATP  ATP+KLA
 NM_008480 laminin, alpha 1 (Lama1), mRNA [NM_008480] KLA .99 1.04 .97 .96 1.01 .99 1.05
ATP 1.01 .99 .98 1.05 .99 1.09 .99
KLA/ATP 1.00 .97 .86 1.04 1.05 .99 1.00
Lama2
KLA  ATP  ATP+KLA
 AK046114 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230342M05 product:laminin, alpha 2, full insert sequence. [AK046114] KLA 1.06 1.00 .95 1.10 1.04 .99 .96
ATP .98 1.09 1.00 .97 .96 1.12 1.01
KLA/ATP .94 1.04 1.05 1.00 .99 1.00 .98
Lama2
KLA  ATP  ATP+KLA
 NM_008481 laminin, alpha 2 (Lama2), mRNA [NM_008481] KLA .96 .99 .96 1.02 .95 1.00 .97
ATP 1.05 1.00 1.01 .94 1.01 1.04 .96
KLA/ATP .99 1.04 1.06 1.10 .98 .95 .97
Lama2
KLA  ATP  ATP+KLA
 U12147 laminin-2 alpha2 chain mRNA, complete cds. [U12147] KLA .96 1.00 .99 1.00 .98 1.02 1.03
ATP 1.01 .99 1.02 1.04 1.01 .99 1.02
KLA/ATP 1.00 1.01 1.00 1.01 .99 1.04 1.00
Lama3
KLA  ATP  ATP+KLA
 XM_140451 gb|PREDICTED: Mus musculus laminin, alpha 3, transcript variant 1 (Lama3), mRNA [XM_140451] KLA .76 .75 .73 .75 .71 .74 .67
ATP 1.04 1.12 1.05 1.20 .88 .73 .78
KLA/ATP .77 .81 .78 .82 .78 .71 .70
Lama4
KLA  ATP  ATP+KLA
 NM_010681 laminin, alpha 4 (Lama4), mRNA [NM_010681] KLA .99 .99 1.01 1.02 .98 .97 .96
ATP 1.00 1.08 1.05 1.05 1.03 1.04 .96
KLA/ATP 1.00 1.03 .93 1.00 .94 .90 .95
Lama5
KLA  ATP  ATP+KLA
 NM_001081171 laminin, alpha 5 (Lama5), mRNA [NM_001081171] KLA 1.11 1.07 1.09 1.00 .96 1.00 1.01
ATP 1.01 .99 1.03 1.01 1.00 .99 .99
KLA/ATP 1.12 1.08 1.05 1.04 .99 1.09 1.04
Lamb1-1
KLA  ATP  ATP+KLA
 NM_008482 laminin B1 subunit 1 (Lamb1-1), mRNA [NM_008482] KLA .93 .99 1.10 1.01 .95 1.00 .86
ATP .99 1.13 1.06 .99 1.07 .99 .97
KLA/ATP 1.00 1.06 .98 .95 .93 .89 1.04
Lamb2
KLA  ATP  ATP+KLA
 NM_008483 laminin, beta 2 (Lamb2), mRNA [NM_008483] KLA .93 .90 .95 .81 .79 .58 .37
ATP 1.01 1.09 .95 .99 .80 .81 .38
KLA/ATP .96 .87 1.00 .91 .72 .60 .38
Lamb3
KLA  ATP  ATP+KLA
 NM_008484 laminin, beta 3 (Lamb3), mRNA [NM_008484] KLA 1.00 .97 1.02 .98 1.00 1.04 .93
ATP 1.01 1.01 .91 .97 .89 1.04 1.03
KLA/ATP 1.00 .95 .97 1.00 .95 .87 1.02
Lamc1
KLA  ATP  ATP+KLA
 J03484 gb|Mouse laminin B2 chain mRNA, complete cds [J03484] KLA 1.14 1.01 1.04 .87 .82 .63 .75
ATP .99 1.09 1.07 1.14 1.36 2.38 .66
KLA/ATP 1.04 1.10 .95 1.12 1.30 1.70 .68
Lamc2
KLA  ATP  ATP+KLA
 AF106279 laminin gamma2 chain mRNA, partial cds. [AF106279] KLA 1.03 1.04 1.03 1.09 .97 .97 .98
ATP 1.04 1.04 1.16 1.48 1.46 1.29 1.26
KLA/ATP 1.04 1.00 1.03 1.06 .95 .99 1.08
Lamc2
KLA  ATP  ATP+KLA
 NM_008485 laminin, gamma 2 (Lamc2), mRNA [NM_008485] KLA 1.16 1.22 1.23 1.07 1.04 1.12 1.04
ATP 1.01 1.10 2.81 4.58 4.35 3.34 2.36
KLA/ATP 1.31 1.29 1.41 1.40 1.28 1.25 1.49
Lamc3
KLA  ATP  ATP+KLA
 AF083372 laminin 12 gamma 3 chain mRNA, complete cds. [AF083372] KLA .96 .94 .99 .96 .94 1.02 .88
ATP 1.06 1.00 .95 .98 .98 .99 1.02
KLA/ATP .90 .98 1.03 .95 .88 .97 .96
Lamc3
KLA  ATP  ATP+KLA
 NM_011836 laminin gamma 3 (Lamc3), mRNA [NM_011836] KLA 1.00 1.00 1.04 1.04 1.03 1.01 .97
ATP .99 1.06 1.00 .91 .98 .96 1.01
KLA/ATP .98 1.04 1.01 1.02 .96 .95 .98
Mm.19309
9
KLA  ATP  ATP+KLA
 46849811 Unknown KLA 1.32 1.36 1.42 1.17 1.06 .90 .58
ATP .98 1.12 1.41 1.81 1.44 1.14 .89
KLA/ATP 1.39 1.55 1.57 2.02 1.43 1.12 .74
Mm.24866
2
KLA  ATP  ATP+KLA
 94379307 Unknown KLA 1.22 1.20 1.16 1.28 1.21 1.29 1.47
ATP 1.04 1.00 1.11 1.01 1.04 1.05 1.19
KLA/ATP 1.14 1.12 1.17 1.12 1.17 1.27 3.47
Mm.25806
5
KLA  ATP  ATP+KLA
 148747407 Unknown KLA 1.05 1.02 1.03 1.00 .99 1.05 .94
ATP .98 .98 1.03 1.02 .99 1.06 1.03
KLA/ATP 1.01 1.02 1.03 1.01 .96 .98 1.01
Mm.42523
6
KLA  ATP  ATP+KLA
 117320553 Unknown KLA .98 .98 1.03 1.00 .99 1.02 1.02
ATP 1.01 .99 1.03 1.02 1.05 .94 .96
KLA/ATP 1.08 1.04 1.06 1.01 1.00 1.01 1.05
Mm.46042
5
KLA  ATP  ATP+KLA
 145699103 Unknown KLA .97 1.06 1.00 1.00 1.04 1.00 1.06
ATP .98 1.03 .96 .96 1.00 1.05 .96
KLA/ATP .99 .95 1.04 .97 1.01 .98 .93
Mm.4987
KLA  ATP  ATP+KLA
 160358832 Unknown KLA 1.04 1.02 1.05 1.00 1.06 1.02 1.00
ATP 1.11 1.00 1.08 1.01 1.05 1.09 1.04
KLA/ATP 1.08 1.05 .94 1.04 1.06 1.11 .99
Npnt
KLA  ATP  ATP+KLA
 NM_033525 nephronectin (Npnt), transcript variant 1, mRNA [NM_033525] KLA 1.00 1.03 1.00 .99 .96 .99 .98
ATP .98 1.03 1.03 1.01 .97 .98 1.04
KLA/ATP 1.01 .96 1.00 1.03 .98 .99 1.03
Reln
KLA  ATP  ATP+KLA
 NM_011261 reelin (Reln), mRNA [NM_011261] KLA 1.00 1.00 .98 1.03 1.00 .99 .99
ATP 1.00 .99 1.05 1.08 1.01 .99 1.00
KLA/ATP 1.01 1.02 1.05 1.03 .98 .98 .98
Sdc1
KLA  ATP  ATP+KLA
 NM_011519 syndecan 1 (Sdc1), mRNA [NM_011519] KLA 1.40 1.34 1.52 1.50 1.64 2.31 2.39
ATP 1.20 1.20 1.28 2.62 10.61 16.35 9.95
KLA/ATP 1.61 1.71 1.60 3.94 11.52 15.28 20.29
Sdc4
KLA  ATP  ATP+KLA
 NM_011521 syndecan 4 (Sdc4), mRNA [NM_011521] KLA 11.43 12.18 10.95 10.65 8.99 5.55 1.88
ATP 1.01 1.13 1.24 3.44 3.56 2.85 2.00
KLA/ATP 11.15 13.40 11.98 16.31 11.68 6.11 4.76
Spp1
KLA  ATP  ATP+KLA
 NM_009263 secreted phosphoprotein 1 (Spp1), mRNA [NM_009263] KLA 1.41 1.62 1.39 1.31 1.31 1.00 .51
ATP 1.08 1.21 1.49 1.79 2.55 3.51 3.41
KLA/ATP 1.40 1.54 1.51 1.43 2.01 3.18 2.46
Sv2a
KLA  ATP  ATP+KLA
 NM_022030 synaptic vesicle glycoprotein 2 a (Sv2a), mRNA [NM_022030] KLA .89 .90 .91 .90 .88 .87 .84
ATP .98 .95 .95 .98 .93 .87 .89
KLA/ATP .94 .88 .93 .91 1.02 .87 .85
Sv2b
KLA  ATP  ATP+KLA
 AK035927 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630018J20 product:SYNAPTIC VESICLE PROTEIN 2B homolog [Rattus norvegicus], full insert sequence. [AK035927] KLA .97 1.05 .90 .96 .99 .99 1.02
ATP .99 .99 1.00 1.05 .95 1.01 1.02
KLA/ATP 1.01 1.02 .90 1.00 1.00 .96 .99
Sv2b
KLA  ATP  ATP+KLA
 NM_153579 synaptic vesicle glycoprotein 2 b (Sv2b), transcript variant 1, mRNA [NM_153579] KLA 1.03 1.07 .98 1.05 1.04 1.01 1.04
ATP .97 1.06 1.00 .94 .97 1.02 1.03
KLA/ATP .95 .99 1.06 .99 .99 .95 1.07
Thbs1
KLA  ATP  ATP+KLA
 NM_011580 thrombospondin 1 (Thbs1), mRNA [NM_011580] KLA 2.22 2.22 2.74 3.10 4.57 7.17 7.22
ATP 1.16 2.53 8.45 12.26 15.50 43.06 35.83
KLA/ATP 2.46 3.43 8.29 17.50 28.16 46.17 54.67
Thbs2
KLA  ATP  ATP+KLA
 NM_011581 thrombospondin 2 (Thbs2), mRNA [NM_011581] KLA .99 1.03 1.04 1.03 1.04 1.17 1.03
ATP 1.01 1.04 1.01 1.02 .98 1.03 .97
KLA/ATP 1.08 1.04 .95 1.05 1.15 1.14 1.04
Thbs3
KLA  ATP  ATP+KLA
 NM_013691 thrombospondin 3 (Thbs3), mRNA [NM_013691] KLA .86 .93 .86 .95 .90 .79 .79
ATP 1.06 1.02 1.11 1.10 .96 1.03 1.07
KLA/ATP .90 .88 .92 .92 .98 .96 .98
Thbs4
KLA  ATP  ATP+KLA
 NM_011582 thrombospondin 4 (Thbs4), mRNA [NM_011582] KLA 1.16 1.13 1.19 1.13 1.13 1.16 1.07
ATP 1.00 1.14 1.07 .99 1.07 1.25 1.10
KLA/ATP 1.16 1.18 1.24 1.55 1.55 1.94 1.48
Tnc
KLA  ATP  ATP+KLA
 AK048765 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230053B09 product:tenascin C, full insert sequence. [AK048765] KLA 1.22 1.24 1.38 1.04 .98 1.03 1.03
ATP 1.01 1.04 1.02 1.08 .99 1.04 1.04
KLA/ATP 1.28 1.36 1.19 1.05 1.03 1.06 1.04
Tnc
KLA  ATP  ATP+KLA
 NM_011607 tenascin C (Tnc), mRNA [NM_011607] KLA 1.41 1.56 1.78 1.51 1.60 1.33 1.01
ATP 1.05 1.05 1.05 1.18 1.03 1.24 1.11
KLA/ATP 1.46 1.74 1.63 1.64 1.29 1.26 1.12
Tnn
KLA  ATP  ATP+KLA
 NM_177839 tenascin N (Tnn), mRNA [NM_177839] KLA 1.62 1.81 1.88 1.81 1.51 1.28 1.02
ATP 1.00 1.12 1.10 1.04 1.05 1.18 1.02
KLA/ATP 1.79 1.82 1.73 1.57 1.32 1.13 1.12
Tnr
KLA  ATP  ATP+KLA
 NM_022312 tenascin R (Tnr), mRNA [NM_022312] KLA .98 .94 1.01 1.02 .96 .98 .94
ATP 1.08 .97 1.00 .95 1.01 .89 1.10
KLA/ATP .98 1.03 1.00 .97 .94 .91 1.03
Tnxb
KLA  ATP  ATP+KLA
 NM_031176 tenascin XB (Tnxb), mRNA [NM_031176] KLA 1.02 .95 1.00 .96 .97 .99 .98
ATP .99 1.02 1.00 1.02 1.00 .98 1.01
KLA/ATP .99 1.04 1.01 .95 .99 .95 .97
Vtn
KLA  ATP  ATP+KLA
 NM_011707 vitronectin (Vtn), mRNA [NM_011707] KLA 1.05 1.05 1.01 1.00 .97 1.04 .95
ATP .94 .99 1.00 .94 .96 1.04 1.09
KLA/ATP .97 1.00 1.02 .99 .98 .94 .98
Vwf
KLA  ATP  ATP+KLA
 AK044921 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130011O06 product:VON WILLEBRAND FACTOR (FRAGMENT) homolog [Saguinus bicolor], full insert sequence. [AK044921] KLA 1.02 .96 .97 .95 .97 1.00 .91
ATP 1.01 1.03 .93 1.02 1.01 1.00 1.08
KLA/ATP .99 .93 .99 .96 1.02 1.01 1.08
Vwf
KLA  ATP  ATP+KLA
 NM_011708 Von Willebrand factor homolog (Vwf), mRNA [NM_011708] KLA .56 .56 .51 .41 .37 .50 .33
ATP 1.09 .99 .77 .88 3.26 2.28 .64
KLA/ATP .65 .58 .46 .52 2.61 3.48 1.38